Glass House Brands (GLAS) Intangibles (2020 - 2026)
Glass House Brands' (GLAS) quarterly Intangibles came in at $11.6 million in Q1 2026, down 4.08% year-on-year from $12.1 million in Q1 2025, and little changed on a QoQ basis from $11.6 million in Q4 2025.
Glass House Brands (GLAS) Intangibles (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Intangibles data on file, last reported at $11.6 million in Q1 2026.
- On a quarterly basis, Intangibles fell 4.08% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 4.08% decrease from a year earlier, with the FY2025 full-year figure at $11.6 million, down 18.47% from the prior year.
- Intangibles for Q1 2026 stood at $11.6 million, roughly flat from $11.6 million in the prior quarter.
- Over the last five years, Intangibles for GLAS reached as high as $47.2 million in Q3 2022 and fell as low as $5.6 million in Q1 2022.
- Historically, Intangibles has averaged $20.2 million across 5 years, with a median of $20.9 million in 2024.
- On a YoY basis, Intangibles climbed as much as 4410.07% in 2022 and fell as far as 96.84% in 2022.
- Year by year, Intangibles stood at $26.2 million in 2022, then decreased by 19.09% to $21.2 million in 2023, then slumped by 33.06% to $14.2 million in 2024, then decreased by 18.47% to $11.6 million in 2025, then increased by 0.42% to $11.6 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $11.6 million in Q1 2026, $11.6 million in Q4 2025, and $11.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 5.29 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 11.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.63 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 11.76 Mn |
| Jun 30, 2025 | 11.94 Mn |
| Mar 31, 2025 | 12.12 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Sep 30, 2024 | 14.38 Mn |
| Jun 30, 2024 | 20.87 Mn |
| Mar 31, 2024 | 21.01 Mn |
| Dec 31, 2023 | 21.21 Mn |
| Sep 30, 2023 | 29.33 Mn |
| Jun 30, 2023 | 29.57 Mn |
| Mar 31, 2023 | 29.98 Mn |
| Dec 31, 2022 | 26.22 Mn |
| Sep 30, 2022 | 47.16 Mn |
| Jun 30, 2022 | 24.53 Mn |
| Mar 31, 2022 | 5.59 Mn |
| Dec 31, 2021 | 581,333.00 |
| Sep 30, 2021 | 4.92 Mn |
| Mar 31, 2021 | 176.92 Mn |